G. LE QUELLENEC, X. Muracciole, A. Ducassou, C. Bartau, E. Jouglar, V. Martin, D. Mitrea, L. Duvergé, M. Jolnerovski, A. Jorand, J. Bouter, M. Cantaloube, G. Beldjoudi, L. Claude
{"title":"如何改进新放射治疗指南的实施?国家培训讲习班的兴趣和限制","authors":"G. LE QUELLENEC, X. Muracciole, A. Ducassou, C. Bartau, E. Jouglar, V. Martin, D. Mitrea, L. Duvergé, M. Jolnerovski, A. Jorand, J. Bouter, M. Cantaloube, G. Beldjoudi, L. Claude","doi":"10.1016/j.ijrobp.2024.11.048","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>The Inter-Ewing-1 trial is currently implemented in several countries with two randomized questions regarding radiotherapy: (1) dose escalation in definitive radiotherapy and (2) dose optimisation in post-operative radiotherapy. A prospective radiotherapy quality assurance (Quartet RTQA) is an essential part of the trial. Before opening the trial, the French Radiotherapy Group Society organised a delineation workshop to train the participants and evaluate the benefit on the delineation quality.</div></div><div><h3>Methods</h3><div>Before the workshop, all the participants were asked to delineate the target volumes of a benchmark case as recommended in the guidelines. During the workshop, the case and delineations were reviewed. A second delineation round was asked after the workshop.</div><div>Quantitative volume (Dice coefficient (DC)), dimension (Hausdorff distance (HD)), concordance and discordance index comparisons with the reference contours were made for GTVp_Pre, GTVp_Post, CTVp_Pre and CTVp_Post, before and after workshop.</div></div><div><h3>Results</h3><div>Eight centers provided both pre- and post-workshop delineations. Before the workshop, the median [Q25; Q75] DC for CTVp_Pre and CTVp_Post were 0.670 [0.629; 0.723] and 0.552 [0.428. 0.579] respectively versus 0.673 [0.656; 0.752] (Paired T-Test Welch, p=0.06) and 0.686 [0.574. 0.756] (Paired T-Test Welch, p=0.015) after the training.</div><div>Before the workshop, the median [Q25; Q75] HD for CTVp_Pre and CTVp_Post were 24.4 [19.0; 27.5] and 33.5 [27.1; 49.0] respectively versus 24.7 [19.8; 27.5] (Wilcoxon Signed Rank Test, p=0,830) and 22.8 [20.9; 35.6] (Wilcoxon Signed Rank Test, p=0.110) after the training. The results were similar for the GTVp_Pre and GTVp_Post and will be detailed at the congress.</div></div><div><h3>Conclusion</h3><div>The delineation of target volumes in ES remains difficult despite guidelines. These results confirm that training makes it possible to improve practices but this remains insufficient. This result highlights the importance of developing prospective RTQA to improve the quality of treatments.</div></div>","PeriodicalId":14215,"journal":{"name":"International Journal of Radiation Oncology Biology Physics","volume":"121 3","pages":"Page e13"},"PeriodicalIF":6.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How to Improve the Implementation of New Radiotherapy Guidelines? Interests and Llimits of a National Training Workshop\",\"authors\":\"G. LE QUELLENEC, X. Muracciole, A. Ducassou, C. Bartau, E. Jouglar, V. Martin, D. Mitrea, L. Duvergé, M. Jolnerovski, A. Jorand, J. Bouter, M. Cantaloube, G. Beldjoudi, L. Claude\",\"doi\":\"10.1016/j.ijrobp.2024.11.048\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>The Inter-Ewing-1 trial is currently implemented in several countries with two randomized questions regarding radiotherapy: (1) dose escalation in definitive radiotherapy and (2) dose optimisation in post-operative radiotherapy. A prospective radiotherapy quality assurance (Quartet RTQA) is an essential part of the trial. Before opening the trial, the French Radiotherapy Group Society organised a delineation workshop to train the participants and evaluate the benefit on the delineation quality.</div></div><div><h3>Methods</h3><div>Before the workshop, all the participants were asked to delineate the target volumes of a benchmark case as recommended in the guidelines. During the workshop, the case and delineations were reviewed. A second delineation round was asked after the workshop.</div><div>Quantitative volume (Dice coefficient (DC)), dimension (Hausdorff distance (HD)), concordance and discordance index comparisons with the reference contours were made for GTVp_Pre, GTVp_Post, CTVp_Pre and CTVp_Post, before and after workshop.</div></div><div><h3>Results</h3><div>Eight centers provided both pre- and post-workshop delineations. Before the workshop, the median [Q25; Q75] DC for CTVp_Pre and CTVp_Post were 0.670 [0.629; 0.723] and 0.552 [0.428. 0.579] respectively versus 0.673 [0.656; 0.752] (Paired T-Test Welch, p=0.06) and 0.686 [0.574. 0.756] (Paired T-Test Welch, p=0.015) after the training.</div><div>Before the workshop, the median [Q25; Q75] HD for CTVp_Pre and CTVp_Post were 24.4 [19.0; 27.5] and 33.5 [27.1; 49.0] respectively versus 24.7 [19.8; 27.5] (Wilcoxon Signed Rank Test, p=0,830) and 22.8 [20.9; 35.6] (Wilcoxon Signed Rank Test, p=0.110) after the training. The results were similar for the GTVp_Pre and GTVp_Post and will be detailed at the congress.</div></div><div><h3>Conclusion</h3><div>The delineation of target volumes in ES remains difficult despite guidelines. These results confirm that training makes it possible to improve practices but this remains insufficient. This result highlights the importance of developing prospective RTQA to improve the quality of treatments.</div></div>\",\"PeriodicalId\":14215,\"journal\":{\"name\":\"International Journal of Radiation Oncology Biology Physics\",\"volume\":\"121 3\",\"pages\":\"Page e13\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology Biology Physics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0360301624036228\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology Biology Physics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0360301624036228","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
inter - wing-1试验目前在几个国家进行,有两个关于放疗的随机问题:(1)最终放疗的剂量递增和(2)术后放疗的剂量优化。前瞻性放疗质量保证(四方RTQA)是试验的重要组成部分。在试验开始之前,法国放射治疗协会组织了一个圈定研讨会来培训参与者并评估圈定质量的益处。方法在研讨会开始前,所有参与者都被要求按照指南的建议描述基准病例的目标体积。在研讨会期间,对案例和描述进行了回顾。讲习班结束后要求进行第二轮划定。对GTVp_Pre、GTVp_Post、CTVp_Pre和CTVp_Post在研讨会前后的定量体积(Dice系数(DC))、尺寸(Hausdorff distance (HD))以及与参考轮廓的一致性和不一致性指标进行比较。结果8个中心提供了研讨会前后的描述。车间前,中位数[Q25;Q75] CTVp_Pre和CTVp_Post的DC为0.670 [0.629;0.723]和0.552[0.428]。0.579] vs . 0.673 [0.656;0.752](配对t检验Welch, p=0.06)和0.686[0.574]。0.756](配对t检验Welch, p=0.015)。车间前,中位数[Q25;Q75] CTVp_Pre和CTVp_Post的HD为24.4 [19.0;27.5]和33.5 [27.1;49.0] vs . 24.7 [19.8;27.5] (Wilcoxon sign Rank检验,p= 0.830)和22.8 [20.9;35.6] (Wilcoxon sign Rank检验,p=0.110)。GTVp_Pre和GTVp_Post的结果相似,将在大会上详细说明。结论尽管有指南,ES靶体积的描绘仍然很困难。这些结果证实,培训使改进实践成为可能,但这仍然不够。这一结果强调了开发前瞻性RTQA对提高治疗质量的重要性。
How to Improve the Implementation of New Radiotherapy Guidelines? Interests and Llimits of a National Training Workshop
Objectives
The Inter-Ewing-1 trial is currently implemented in several countries with two randomized questions regarding radiotherapy: (1) dose escalation in definitive radiotherapy and (2) dose optimisation in post-operative radiotherapy. A prospective radiotherapy quality assurance (Quartet RTQA) is an essential part of the trial. Before opening the trial, the French Radiotherapy Group Society organised a delineation workshop to train the participants and evaluate the benefit on the delineation quality.
Methods
Before the workshop, all the participants were asked to delineate the target volumes of a benchmark case as recommended in the guidelines. During the workshop, the case and delineations were reviewed. A second delineation round was asked after the workshop.
Quantitative volume (Dice coefficient (DC)), dimension (Hausdorff distance (HD)), concordance and discordance index comparisons with the reference contours were made for GTVp_Pre, GTVp_Post, CTVp_Pre and CTVp_Post, before and after workshop.
Results
Eight centers provided both pre- and post-workshop delineations. Before the workshop, the median [Q25; Q75] DC for CTVp_Pre and CTVp_Post were 0.670 [0.629; 0.723] and 0.552 [0.428. 0.579] respectively versus 0.673 [0.656; 0.752] (Paired T-Test Welch, p=0.06) and 0.686 [0.574. 0.756] (Paired T-Test Welch, p=0.015) after the training.
Before the workshop, the median [Q25; Q75] HD for CTVp_Pre and CTVp_Post were 24.4 [19.0; 27.5] and 33.5 [27.1; 49.0] respectively versus 24.7 [19.8; 27.5] (Wilcoxon Signed Rank Test, p=0,830) and 22.8 [20.9; 35.6] (Wilcoxon Signed Rank Test, p=0.110) after the training. The results were similar for the GTVp_Pre and GTVp_Post and will be detailed at the congress.
Conclusion
The delineation of target volumes in ES remains difficult despite guidelines. These results confirm that training makes it possible to improve practices but this remains insufficient. This result highlights the importance of developing prospective RTQA to improve the quality of treatments.
期刊介绍:
International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.
This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.